The Russian-Born CRO Leader Trying To Keep Clinical Trials Going In Ukraine

Under Brutal Onslaught, Patient Needs Remain Paramount

Contract research organization Cromos Pharma is looking to transfer patients and studies to west Ukraine or neigboring Poland – but maintaining data integrity in a war is against the odds.

1200 — More than 3.6 million people have fled the conflict in Ukraine, - including child cancer patients pictured - disrupting vital care and clinical trials . • Source: Getty Images

While the world watches in horror at Russia’s intensifying assault on Ukraine and the terrible impact on its people, a small number of biopharma and contract research organization personnel in the country are trying to maintain care for people who have taken part in clinical trials – and are even trying to ensure some can remain in studies.

One man attempting to ‘keep the lights on’ amid the devastation is Vlad Bogin, CEO of Cromos Pharma, a mid-sized...